News
- Author:
- Lucy Hicks
Publish date: March 24, 2023
“Most of the biologic therapies had similar rates of developing ILD, but the JAK inhibitor tofacitinib had a reduced risk,” said study first author...
News
- Author:
- Lucy Hicks
Publish date: March 20, 2023
For those runners who had undergone knee or hip surgery or had a previous hip or knee injury that prevented running, the likelihood of having arthr...
News
- Author:
- Lucy Hicks
Publish date: March 20, 2023
The guidelines also state that obesity alone should not be a reason to delay surgery.
News
- Author:
- Lucy Hicks
Publish date: March 14, 2023
“Risk-based testing alone has not identified most persons living with chronic HBV infection and is considered inefficient for providers to implemen...
News
- Author:
- Lucy Hicks
Publish date: March 9, 2023
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors (guselkumab, risankizumab, tildrakizumab) was linked to a l...
News
- Author:
- Lucy Hicks
Publish date: March 6, 2023
Despite ILD being a leading cause of death in RA patients, there are no clinical guidelines for monitoring this lung condition in this population, ...
News
- Author:
- Lucy Hicks
Publish date: March 4, 2023
“Given the possibility of infectious graft complications, post–liver transplant follow-ups may need to be more comprehensive and frequent in these ...
News
- Author:
- Lucy Hicks
Publish date: March 1, 2023
The interleukin-6 receptor antagonist sarilumab (Kevzara) will be indicated in adults who have had an inadequate response to corticosteroids or cou...
News
- Author:
- Lucy Hicks
Publish date: February 23, 2023
Physicians surveyed from four different specialties reported that they were generally comfortable prescribing biosimilars, but greater discounts ar...
News
- Author:
- Lucy Hicks
Publish date: February 23, 2023
An announcement released Wednesday adds to a Read More
News
- Author:
- Lucy Hicks
Publish date: February 14, 2023
Nearly one-third of girls (30%) reported seriously considering suicide, up from 19% in 2011.
News
- Author:
- Lucy Hicks
Publish date: February 14, 2023
Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune disea...
News
- Author:
- Lucy Hicks
Publish date: February 1, 2023
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
News
- Author:
- Lucy Hicks
Publish date: January 31, 2023
The program will require a donor (and a support person) to travel to the recipient’s transplant center where the surgery will be performed. A donor...
News
- Author:
- Lucy Hicks
Publish date: December 22, 2022
FDA has approved the medication lenacapavir (Sunlenca) for adults living with multidrug resistant HIV-1 infection.
